Cantor Fitzgerald Analysts Lower Earnings Estimates for PTCT
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Research analysts at Cantor Fitzgerald reduced their FY2026 earnings per share estimates for shares of PTC Therapeutics in a report issued on Tuesday, July 29th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biopharmaceutical company will earn ($4.36) per share for the year, down from their […]
More Stories
New Target CEO Forecasts Turnaround to Retailer’s Lackluster Sales in 2025
By Rob Sabo Target Corp. reported on March 3 slumping sales in the fourth quarter of fiscal 2025, but its...
France Sending Nuclear-Powered Aircraft Carrier to Mediterranean: Macron
By T.J. Muscaro France’s nuclear-powered aircraft carrier Charles de Gaulle has set sail for the Eastern Mediterranean under the orders...
Trump Says US Has ‘Virtually Unlimited’ Weapons Stockpiles
By Guy Birchall President Donald Trump said on March 3 that the United States has a “virtually unlimited supply” of...
Trump Criticizes Starmer, Says Special Relationship in Peril
By Owen Evans President Donald Trump has criticised British Prime Minister Keir Starmer and warned that the historic U.S.–UK Special...
Alone Season 11 is Live on Netflix: Know About Release Date, Participants, and Winner
Why is Alone season 11 getting a sudden hype after its original release date on 13 June 2024? There are...
Who is George Russell? Number 63 Driver of Formula One Racing
If you follow car racing closely, you must know who is George Russell. One who started as a kart racer...